Bleeding and thromboembolic risks of internal cardioversion for persistent atrial fibrillation. [electronic resource]
- Pacing and clinical electrophysiology : PACE Dec 2002
- 1752-5 p. digital
Publication Type: Journal Article
0147-8389
10.1046/j.1460-9592.2002.01752.x doi
Anticoagulants--therapeutic use Atrial Fibrillation--complications Electric Countershock--adverse effects Female Hemorrhage--etiology Humans Male Middle Aged Retrospective Studies Risk Factors Thromboembolism--etiology Warfarin--therapeutic use